HERCULES, CA — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced the availability of its first iPhone app for free download through Apple’s iTunes App Store. The Bio-Rad Real-Time PCR app provides researchers performing PCR and qPCR with several helpful tools including tutorials, troubleshooting tips, and assay-specific information.

“This reference tool is intended to provide researchers with the information they need to support their PCR and qPCR experiments,” said Dr. Kamni Vijay, Marketing Manager for Genomics, Bio-Rad. “We are putting three of Bio-Rad’s best PCR resources at researcher’s fingertips through their iPhone or iPod Touch.”

The iPhone app includes the following:

* Real-Time PCR Amplification Guide for designing, analyzing, and optimizing real-time PCR experiments

* qPCR Doctor for troubleshooting and resolving problems related to real-time PCR assays

* qPCR Assay Design for guidance on designing a qPCR assay, information on validating and optimizing a qPCR assay and different methods for analyzing qPCR data

The Bio-Rad Real-Time PCR App is derived from two trusted amplification sources: Bio-Rad’s Real-Time PCR Applications Guide and the Gene Expression Gateway microsite (www.bio-rad.com/genomics). Additional features will be added to the app on an ongoing basis. The app runs on Apple’s iPhone or iPod Touch and can be downloaded here.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), has remained at the center of scientific discovery for more than 50 years, manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets. Bio-Rad is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 85,000 research and industry customers worldwide through its global network of operations. The company employs over 6,500 people globally and had revenues exceeding $1.7 billion in 2008. For more information, visit www.bio-rad.com.

This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally can be identified by the use of forward-looking terminology such as, “believe,” “expect,” “may,” “will,” “intend,” “estimate,” “continue,” or similar expressions or the negative of those terms or expressions. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. For further information regarding the Company’s risks and uncertainties, please refer to the “Risk Factors” in the Company’s public reports filed with the Securities and Exchange Commission, including the Company’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. The Company cautions you not to place undue reliance on forward-looking statements, which reflect an analysis only and speak only as of the date hereof. Bio-Rad Laboratories, Inc., disclaims any obligation to update these forward-looking statements.